Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; nitrogen - pharmorubicin has produced responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of breast cancer; gastric cancer; ovarian cancer; small cell lung cancer; lymphoma (non-hodgkin?s lymphoma); advanced/metastatic soft tissue sarcoma; superficial bladder cancer (tis; ta). in bladder cancer, pharmorubicin is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grade 2 and 3).

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; nitrogen - taiwan: - breast cancer - malignant lymphoma - soft tissue sarcoma - gastric cancer - lung cancer - ovarian tumour

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; nitrogen - taiwan: - breast cancer - malignant lymphoma - soft tissue sarcoma - gastric cancer - lung cancer - ovarian tumour

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium chloride - pharmorubicin has produced responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of: breast cancer; gastric cancer; ovarian cancer; small cell lung cancer; lymphoma (non-hodgkin's lymphoma); advanced/metastatic soft tissue sarcoma; superficial bladder cancer (tis; ta). in bladder cancer, pharmorubicin is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grade 2 and 3).

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections - pharmorubicin has produced responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of: breast cancer; gastric cancer; ovarian cancer; small cell lung cancer; lymphoma (non-hodgkin's lymphoma); advanced/metastatic soft tissue sarcoma; superficial bladder cancer (tis; ta). in bladder cancer, pharmorubicin is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grade 2 and 3).

Canada - English - Health Canada

pharmascience inc - epirubicin hydrochloride - solution - 2mg - epirubicin hydrochloride 2mg - antineoplastic agents

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - epirubicin hydrochloride, quantity: 50 mg - injection - excipient ingredients: lactose monohydrate - epirubicin hypdrochloride for injection is indicated as a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer.

Canada - English - Health Canada

pharmascience inc - epirubicin hydrochloride - solution - 2mg - epirubicin hydrochloride 2mg - antineoplastic agents

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections - pharmorubicin has produced responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of: breast cancer; gastric cancer; ovarian cancer; small cell lung cancer; lymphoma (non-hodgkin's lymphoma); advanced/metastatic soft tissue sarcoma; superficial bladder cancer (tis; ta). in bladder cancer, pharmorubicin is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grade 2 and 3).

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections - pharmorubicin has produced responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of: breast cancer; gastric cancer; ovarian cancer; small cell lung cancer; lymphoma (non-hodgkin's lymphoma); advanced/metastatic soft tissue sarcoma; superficial bladder cancer (tis; ta). in bladder cancer, pharmorubicin is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grade 2 and 3).